These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21229)

  • 41. Dopamine neurons: effect of lergotrile on unit activity and transmitter synthesis.
    Walters JR; Lakoski JM; Baring MD; Eng N
    Eur J Pharmacol; 1979 Dec; 60(2-3):199-210. PubMed ID: 43259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
    Blackburn KJ; Bremner RM; Greengrass PM; Morville M; Davey MJ
    Br J Pharmacol; 1978 Nov; 64(3):413P. PubMed ID: 31219
    [No Abstract]   [Full Text] [Related]  

  • 44. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens.
    György L; Orr Z; Folly G; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):55-64. PubMed ID: 6268006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
    Tissari AH; Atzori L; Galdieri MT
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):89-91. PubMed ID: 6843693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC; Houwing HA; Horn AS
    Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
    Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
    Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.
    Fuller RW; Perry KW
    J Neural Transm; 1978; 42(1):23-35. PubMed ID: 641542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.
    Kebabian JW; Calne DB; Kebabian PR
    Commun Psychopharmacol; 1977; 1(4):311-8. PubMed ID: 615694
    [No Abstract]   [Full Text] [Related]  

  • 53. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine agonist-induced hyperglycemia in rats: effects of lergotrile mesylate.
    Schmidt MJ
    Eur J Pharmacol; 1979 Oct; 59(1-2):95-101. PubMed ID: 41730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
    Le Fur G; Burgevin MC; Malgouris C; Uzan A
    Neuropharmacology; 1979 Jul; 18(7):591-4. PubMed ID: 40153
    [No Abstract]   [Full Text] [Related]  

  • 56. Stimulation of 3H-apomorphine binding by dopamine and bromocriptine.
    Robertson HA
    Eur J Pharmacol; 1980 Jan; 61(2):209-11. PubMed ID: 7353592
    [No Abstract]   [Full Text] [Related]  

  • 57. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
    Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A
    Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
    Saiani L; Trabucchi M; Tonon GC; Spano PF
    Neurosci Lett; 1979 Sep; 14(1):31-6. PubMed ID: 231228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.